A global, multicenter phase III trial, TROPION-Breast02, led by a senior medical oncologist and researcher from the National ...

Researchers at Ben-Gurion University of the Negev have identified a protein that plays a central role in enabling aggressive ...

Mercy Medical Center oncologist Dr. David Rosenberg joins Jenyne to discuss triple-negative breast cancer, and research into ...

A new study called VOICES of Black Women aims to understand why Black women face higher rates of death from cancer and more ...

Onvansertib in combination with trastuzumab deruxtecan demonstrated enhanced antitumor activity, including tumor regression and apoptosis in HER2-low breast cancer models, supporting its potential for ...

Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for ...

Study will evaluate tumor-specific uptake, safety, tolerability, and preliminary efficacy signals of CLR 125 in refractory ...

Kylie Blackney has raised more than $15,000 running fundraiser events for Barwon Health’s Andrew Love Cancer Centre, the same ...

Compounds in dark sweet cherries were studied for effects on aggressive breast cancer. Researchers tested both prevention and ...

Danella Thompson from The Twin Cities is a breast cancer survivor who found Minnesota's Sage Screening Program after her rare ...

Stefanie LeMoigne, who is critically ill with aggressive breast cancer and currently in intensive care in Mexico after ...

VALANX Biotech (VALANX), a biotech company developing novel technology for site-specific protein conjugation in drug discovery, today announced the formation of its Scientific Advisory Board (SAB), ...